ClinicalTrials.Veeva

Menu

Bipolar Disorder in Late Life (BPD)

Duke University logo

Duke University

Status

Completed

Conditions

Bipolar Disorder

Treatments

Drug: Valproic Acid

Study type

Observational

Funder types

Other

Identifiers

NCT00787930
Pro00007867

Details and patient eligibility

About

The purpose of this study is to look at certain structural changes in the brain in people with bipolar disorder or those with a history of Bipolar disorder.

Full description

Individuals with bipolar disorder or those with a history of bipolar disorder may have certain structural changes in their brain. The purpose of this study is to look at those changes, as well as the assessment of risk factors for bipolar disorders, involving both social and psychological aspects of behavior, age, education, marital relations, nutrition, physical activity, etc., compared with persons not having bipolar disorder. These changes in the brain will be measured by Magnetic Resonance Imaging (MRI).

Enrollment

19 patients

Sex

All

Ages

18 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. DSM-IV diagnosis of bipolar Disorder, Manic and mixed episodes.
  2. 18 years of age and older, male or female, any race.
  3. Capacity to give informed consent and follow study procedures.

Exclusion criteria

  1. History of alcohol/drug dependence
  2. Any metal or pacemaker in the body which precludes MRI
  3. Pregnancy
  4. Dementia or other primary psychiatric disorders including substance abuse/dependence, anxiety disorders, schizophrenia
  5. For controls, numbers one through four above as well as any history of depression or the use of antidepressants

Trial design

19 participants in 2 patient groups

Manic Subject with DWM Hyperintensities >2
Description:
Subjects with acute mania who were treated with naturalistic protocol (starting with valproic acid) who had a BOYKO DWM Hyperintensity rating \>2 and a YMRS \<15 at week 3.
Treatment:
Drug: Valproic Acid
Manic Subjects with DWM Hyperintensities <3
Description:
Subjects with acute mania who were treated with naturalistic protocol (starting with valproic acid)who had a BOYKO DWM Hyperintensity rating \<3 and a YMRS \<15 at week 3.
Treatment:
Drug: Valproic Acid

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems